AUD 0.42
(-1.19%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 27.39 Million AUD | -59.16% |
2023 | 67.06 Million AUD | 32.32% |
2022 | 50.68 Million AUD | -40.22% |
2021 | 84.79 Million AUD | -24.54% |
2020 | 112.36 Million AUD | 31.4% |
2019 | 85.51 Million AUD | 462.9% |
2018 | 15.19 Million AUD | 5.9% |
2017 | 14.34 Million AUD | 16.19% |
2016 | 12.34 Million AUD | -17.92% |
2015 | 15.04 Million AUD | 6838.0% |
2014 | 216.8 Thousand AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 45.03 Million AUD | 0.0% |
2024 FY | 27.39 Million AUD | -59.16% |
2024 Q4 | 27.39 Million AUD | 0.0% |
2023 FY | 67.06 Million AUD | 32.32% |
2023 Q4 | 67.06 Million AUD | 0.0% |
2023 Q2 | 88.5 Million AUD | 0.0% |
2022 Q4 | 50.68 Million AUD | 0.0% |
2022 Q2 | 67.49 Million AUD | 0.0% |
2022 FY | 50.68 Million AUD | -40.22% |
2021 FY | 84.79 Million AUD | -24.54% |
2021 Q4 | 84.79 Million AUD | 0.0% |
2021 Q2 | 95.28 Million AUD | 0.0% |
2020 Q4 | 112.36 Million AUD | 0.0% |
2020 FY | 112.36 Million AUD | 31.4% |
2020 Q2 | 81.24 Million AUD | 0.0% |
2019 Q4 | 85.51 Million AUD | 0.0% |
2019 FY | 85.51 Million AUD | 462.9% |
2019 Q2 | 20.51 Million AUD | 0.0% |
2018 Q2 | 16.27 Million AUD | 0.0% |
2018 FY | 15.19 Million AUD | 5.9% |
2018 Q4 | 15.19 Million AUD | 0.0% |
2017 Q2 | 16.33 Million AUD | 0.0% |
2017 Q4 | 14.34 Million AUD | 0.0% |
2017 FY | 14.34 Million AUD | 16.19% |
2016 Q2 | 13.09 Million AUD | 0.0% |
2016 Q4 | 12.34 Million AUD | 0.0% |
2016 FY | 12.34 Million AUD | -17.92% |
2015 Q4 | 1.19 Million AUD | 0.0% |
2015 FY | 15.04 Million AUD | 6838.0% |
2014 FY | 216.8 Thousand AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Memphasys Limited | 12.43 Million AUD | -120.355% |
Race Oncology Limited | 20.22 Million AUD | -35.405% |
AdAlta Limited | 5.57 Million AUD | -391.485% |
Anatara Lifesciences Ltd | 1.67 Million AUD | -1538.751% |
Bio-Gene Technology Limited | 3.15 Million AUD | -766.898% |
BTC Health Limited | 5.14 Million AUD | -431.976% |
CSL Limited | 56.93 Billion AUD | 99.952% |
Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 82.286% |
Cynata Therapeutics Limited | 8.38 Million AUD | -226.532% |
Imugene Limited | 151.39 Million AUD | 81.908% |
NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -403.883% |
PharmAust Limited | 11.12 Million AUD | -146.21% |
Proteomics International Laboratories Limited | 10.87 Million AUD | -151.864% |
Acrux Limited | 8.96 Million AUD | -205.595% |
Botanix Pharmaceuticals Limited | 112.46 Million AUD | 75.645% |
Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 88.149% |
Island Pharmaceuticals Limited | 2.56 Million AUD | -968.074% |
Nyrada Inc. | 5.9 Million AUD | -363.674% |
Orthocell Limited | 26.61 Million AUD | -2.913% |
Radiopharm Theranostics Limited | 72.03 Million AUD | 61.977% |
Starpharma Holdings Limited | 36.81 Million AUD | 25.598% |
Zelira Therapeutics Limited | 5.18 Million AUD | -428.424% |
Arovella Therapeutics Limited | 13.28 Million AUD | -106.181% |
Alterity Therapeutics Limited | 19.22 Million AUD | -42.482% |
Amplia Therapeutics Limited | 14.84 Million AUD | -84.508% |
Biome Australia Limited | 8.27 Million AUD | -230.931% |
Biotron Limited | 493.47 Thousand AUD | -5450.511% |
Chimeric Therapeutics Limited | 15.27 Million AUD | -79.337% |
EZZ Life Science Holdings Limited | 25.55 Million AUD | -7.195% |
Immutep Limited | 147.44 Million AUD | 81.424% |
Invex Therapeutics Ltd | 6.12 Million AUD | -347.552% |
Noxopharm Limited | 6.78 Million AUD | -303.765% |
Patrys Limited | 4.16 Million AUD | -558.174% |
Prescient Therapeutics Limited | 20.39 Million AUD | -34.314% |
PYC Therapeutics Limited | 91.23 Million AUD | 69.979% |
Telix Pharmaceuticals Limited | 398.3 Million AUD | 93.123% |
Dimerix Limited | 32.07 Million AUD | 14.614% |
Hexima Limited | 2.26 Million AUD | -1107.157% |
Neuren Pharmaceuticals Limited | 247.97 Million AUD | 88.954% |
Nanollose Limited | 241.95 Thousand AUD | -11220.655% |
Tissue Repair Ltd | 19.38 Million AUD | -41.264% |
AnteoTech Limited | 9.38 Million AUD | -191.972% |
Recce Pharmaceuticals Ltd | 6.36 Million AUD | -330.017% |
Avecho Biotechnology Limited | 7.31 Million AUD | -274.222% |
Actinogen Medical Limited | 21.31 Million AUD | -28.522% |
Immuron Limited | 15.54 Million AUD | -76.145% |
Argenica Therapeutics Limited | 16.37 Million AUD | -67.244% |